{"entity":{"id":"micsi","kind":"company","name":"MICSI","aka":["Microstructure Imaging, Inc.","Microstructure Imaging"],"tldr":"MICSI makes software that sharpens MRI scans using a mathematical noise-removal method. Its first product is FDA cleared, and the company applies it to prostate cancer imaging and to planning brain tumour surgery.","summary":"Microstructure Imaging, Inc. (MICSI) develops physics-based imaging software for existing MRI and PET scanners. Its first product, MICSI-RMT, uses random matrix theory (MP-PCA) denoising and received FDA 510(k) clearance (K241121) on 17 July 2024 for MRI image enhancement; a PET product has been submitted. The company's site presents prostate diffusion MRI, including detection of low-grade prostate cancer, and brain imaging as use cases, and its chief executive Gregory Lemberskiy and chief technology officer Benjamin Aron trained at NYU. In fiscal year 2026 NCI awarded it USD 1,137,424 under SBIR award 2R44CA257624-02 for non-invasive neurosurgical planning in brain tumours with random matrix theory MRI.","asOf":"2026-11-04","links":[{"label":"Official website","url":"https://www.micsi.com/"},{"label":"FDA 510(k) K241121: MICSI-RMT","url":"https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K241121"},{"label":"NIH RePORTER: SBIR award 2R44CA257624-02","url":"https://reporter.nih.gov/project-details/11407450"}],"tags":[],"related":[],"cancers":[],"sections":["imaging"],"technologies":["mri","mp-mri"],"targets":[],"drugs":["micsi-rmt"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":["The FDA 510(k) record lists the applicant at Jay Street, Brooklyn, NY. Read on micsi.com, the FDA 510(k) database and NIH RePORTER on 4 November 2026."],"provenance":{"editedBy":"OnCo startup monitors","editedOn":"2026-11-04"},"hq":"New York, NY","country":"US","companyType":"imaging","website":"https://www.micsi.com/","stage":"startup","investors":[],"funding":[{"round":"Grant","year":2026,"amountUsd":1137424,"source":"https://reporter.nih.gov/project-details/11407450","note":"NCI SBIR award (R44) 2R44CA257624-02: Non-invasive neurosurgical planning with Random Matrix Theory MRI"}]},"route":"/companies/micsi/","neighbours":{"section":[{"id":"imaging","kind":"section","name":"Imaging","route":"/fronts/imaging/"}],"technology":[{"id":"mri","kind":"technology","name":"MRI","route":"/technologies/mri/"},{"id":"mp-mri","kind":"technology","name":"Multiparametric prostate MRI (PI-RADS)","route":"/technologies/mp-mri/"}],"drug":[{"id":"micsi-rmt","kind":"drug","name":"MICSI-RMT","route":"/drugs/micsi-rmt/"}]}}